Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

[Progress and Challenges in the Application of RhCE Models for Eye Irritation Evaluation of Medical Devices].

Created on 13 Oct 2026

Authors

Xian He, Xin Lu, Xianhua Chen, Kejia Xu

Published in

Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation. Volume 50. Issue 5. Pages 576-583. Sep 30, 2026.

Abstract

Eye irritation evaluation is a critical component of the biocompatibility assessment of ophthalmic medical devices. Driven by the advancement of the "3R" principles for experimental animals, 3D reconstructed human cornea-like epithelium (RhCE) models have attracted considerable research interest as a prominent alternative to traditional Draize rabbit eye tests. This article analyzes the limitations of traditional animal testing and systematically reviews the construction principles, biological characteristics, and current application status of mainstream commercial RhCE models. Furthermore, the applications of evaluation metrics such as MTT tissue viability, transepithelial electrical resistance, and inflammatory cytokine release are discussed in detail. Finally, it explores the current regulatory acceptance status, challenges, and future prospects of RhCE models in medical device regulation, providing a reference for the development of in vitro biological evaluation methods for medical devices in China.

PMID:
42865060
Bibliographic data and abstract were imported from PubMed on 13 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 10
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement